On January 6, 2026, brain-computer interface (BCI) concept stocks on the A-share market once again experienced a frenzy of limit-up surges. Several stocks, such as Nanjing Weisi Medical Technology Co., Ltd., soared to the 20CM limit-up mark. Meanwhile, Chengyitong and some other stocks witnessed significant percentage surges, and Innovative Medical Management Co., Ltd., along with a few others, hit the 10CM limit-up. On the news front, Huashan Hospital, affiliated with Fudan University, achieved a groundbreaking advancement in brain-computer interface implantation technology. The hospital successfully concluded the first clinical trial of China's inaugural fully implantable, wireless, and fully functional "triple-full" brain-computer interface product. This represents a significant leap forward in the field, potentially revolutionizing how we interact with and utilize BCI technology. Simultaneously, Elon Musk revealed that his brain-computer interface venture, Neuralink, is set to commence mass production of BCI devices in 2026. Moreover, the company is transitioning towards a more streamlined and automated surgical procedure, aiming to enhance efficiency and accessibility in BCI implantation.